A Phase II, Randomized Controlled Trial of Foscan-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Recurrent or Persistent Nasopharyngeal Carcinoma
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Temoporfin (Primary)
- Indications Nasopharyngeal cancer
- Focus Therapeutic Use
- 07 Jul 2011 Planned end date changed from 1 Jun 2010 to 1 Oct 2011 as reported by ClinicalTrials.gov.
- 25 Mar 2010 New trial record